EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 93 filers reported holding EDGEWISE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $12,040,873 | 10.34% |
| Novo Holdings A/S | 6,071,703 | $47,055,698 | 3.64% |
| Orbimed Advisors | 14,567,176 | $112,895,614 | 2.05% |
| Opaleye Management Inc. | 815,000 | $6,316,250 | 1.51% |
| Cormorant Asset Management, LP | 2,946,887 | $22,838,374 | 1.28% |
| BioImpact Capital LLC | 712,798 | $5,524,185 | 1.11% |
| DAFNA Capital Management LLC | 519,384 | $4,025,226 | 1.10% |
| Deep Track Capital, LP | 2,750,000 | $21,312,500 | 0.99% |
| EcoR1 Capital, LLC | 3,493,194 | $27,072,254 | 0.66% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $30,481,812 | 0.65% |